Related Experiment Video
Updated: May 13, 2026
05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
Thymic epithelial tumours: from basic principles to individualised treatment strategies
1Dept of Respiratory Medicine, National Expert Centre for Thymic Malignancies, Reference Centre for Orphan Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Lyon, France. nicolas.girard@chu-lyon.fr
Summary
Thymic epithelial tumours, including thymomas and thymic carcinomas, are challenging malignant conditions. Complete surgical resection is key for survival, while novel therapies are emerging for refractory cases.
Area of Science:
- Oncology
- Thoracic Surgery
- Pathology
Background:
- Thymic epithelial tumours (TETs) encompass diverse malignant entities with varying aggressiveness.
- Histopathological classification differentiates thymomas from thymic carcinomas.
- Thymomas are frequently linked to autoimmune disorders.
Purpose of the Study:
- To review the current management strategies for thymic epithelial tumours.
- To highlight the importance of multimodal therapeutic approaches.
- To discuss the need for novel strategies in refractory and advanced TETs.
Main Methods:
- Comprehensive review of the literature on thymic epithelial tumours.
- Analysis of diagnostic and therapeutic paradigms.
- Exploration of emerging molecular targets and personalized medicine.
Main Results:
- Complete surgical resection is the primary curative treatment and a significant prognostic factor.
- Neoadjuvant chemotherapy is utilized for unresectable tumours to facilitate resection.
- Refractory, recurrent, and thymic carcinoma cases require novel treatment strategies.
Conclusions:
- Effective management of TETs relies on multidisciplinary collaboration.
- Personalized treatment approaches are being developed based on genomic insights.
- TETs serve as a model for orphan thoracic oncology research and international collaboration.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...